Article: Clinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics

With the emergence of new viral infections, it is necessary to set up new target-specific assays, based on existing molecular techniques such as real-time PCR, as quickly as possible. Without these diagnostic tools, the geographical spread of new infections, follow-up of the disease outbreak and analysis of the pathogenesis of the disease are not possible. Therefore, the genomic information of the emerging pathogen, diagnostic protocols and standards allowing quality control need to be available in a few days. This can only be implemented with good quality experienced laboratories having suitable infrastructure to establish in-house assays. Even though these molecular tools are available quickly, challenges still remain with what sample types to select for a proper diagnostic value.

Citing Articles

Networking of Public Health Microbiology Laboratories Bolsters Europe's Defenses against Infectious Diseases.

Albiger B, Revez J, Leitmeyer K, Struelens M Front Public Health. 2018; 6:46.

PMID: 29535998 PMC: 5834927. DOI: 10.3389/fpubh.2018.00046.

MERS-CoV: Understanding the Latest Human Coronavirus Threat.

Chafekar A, Fielding B Viruses. 2018; 10(2).

PMID: 29495250 PMC: 5850400. DOI: 10.3390/v10020093.

References

1.

Drosten C, Seilmaier M, Corman V, Hartmann W, Scheible G, Sack S . Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013; 13(9):745-51. PMC: 7164791. DOI: 10.1016/S1473-3099(13)70154-3. View

2.

Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P . Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill. 2014; 19(21). DOI: 10.2807/1560-7917.es2014.19.21.20817. View

3.

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

4.

Drosten C, Doerr H, Lim W, Stohr K, Niedrig M . SARS molecular detection external quality assurance. Emerg Infect Dis. 2005; 10(12):2200-3. PMC: 3323363. DOI: 10.3201/eid1012.040416. View

5.

de Sousa R, Reusken C, Koopmans M . MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol. 2013; 59(1):4-11. PMC: 7108266. DOI: 10.1016/j.jcv.2013.10.030. View

6.

Pas S, Patel P, Reusken C, Domingo C, Corman V, Drosten C . First international external quality assessment of molecular diagnostics for Mers-CoV. J Clin Virol. 2015; 69:81-5. PMC: 7106520. DOI: 10.1016/j.jcv.2015.05.022. View

7.

Zumla A, Hui D, Perlman S . Middle East respiratory syndrome. Lancet. 2015; 386(9997):995-1007. PMC: 4721578. DOI: 10.1016/S0140-6736(15)60454-8. View

8.

Corman V, Muller M, Costabel U, Timm J, Binger T, Meyer B . Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012; 17(49). DOI: 10.2807/ese.17.49.20334-en. View

9.

van Riel D, Munster V, de Wit E, Rimmelzwaan G, Fouchier R, Osterhaus A . Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol. 2007; 171(4):1215-23. PMC: 1988871. DOI: 10.2353/ajpath.2007.070248. View

10.

Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1967-76. DOI: 10.1056/NEJMoa030747. View

11.

Corman V, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M . Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012; 17(39). DOI: 10.2807/ese.17.39.20285-en. View

Clinical Implications of and Lessons Learnt from External Assessment of Mers-CoV Diagnostics